Incremental cost-effectiveness of the second Xpert MTB/RIF assay to detect Mycobacterium tuberculosis

BACKGROUND: Due to the non-homogeneity of specimens collected from tuberculosis (TB) suspects, repeated Xpert MTB/RIF (Xpert) may have potential clinical benefits. Incremental cost-effectiveness was analyzed for the second Xpert assay to detect Mycobacterium tuberculosis (Mtb) and rifampicin (RIF) r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Dis
Autors principals: Wang, Guirong, Wang, Shuqi, Jiang, Guanglu, Fu, Yuhong, Shang, Yuanyuan, Huang, Hairong
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5906334/
https://ncbi.nlm.nih.gov/pubmed/29707322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.02.60
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars